Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
OwnerThomas W. Leonard, R. Forrest Waldoninventors
Life of this patent
Estimating the term…
Abstract
The present invention combines the administration of estrogens with the administration of non-aromatizing androgens to treat hormonal deficiencies in women undergoing estrogen replacement therapy.
Claims28
A method of treating hormonal deficiencies in a woman undergoing estrogen replacement therapy, the method comprising administering to said woman, continuously and uninterruptedly, a therapeutic effective amount of both estrogen and a non-aromatizing androgen in daily dosages.
A method of treating hormonal deficiencies in a woman undergoing estrogen replacement therapy, the method comprising administering to said woman, continuously and uninterruptedly, a therapeutically effective amount of both estrogen and androgen in daily dosages of an estrogenic compound equivalent to oral estradiol dosages of about 0.1 to 3 mg, and of a non-aromatizing androgenic compound equivalent to oral dosages of about 0.1 to 10 mg.
A method of treating hormonal deficiencies in a woman undergoing estrogen replacement therapy comprising cyclically administering to said woman an estrogenic compound, and continuously and uninterruptedly administering to said woman a non-aromatizing androgenic compound.
A method of treating hormonal deficiencies in a woman undergoing estrogen replacement therapy comprising continuously and uninterruptedly administering daily dosages of a therapeutically effective amount of an estrogenic compound equivalent to estradiol dosages of about 0.1 to 3 mg, and continuously and uninterruptedly administering to said woman a therapeutically effective amount of a non-aromatizing androgenic compound equivalent to oral dosages of about 0.1 to 10 mg.
A method of treating hormonal deficiencies in a woman undergoing estrogen replacement therapy comprising continuously and uninterruptedly administering to said woman an estrogenic compound, and continuously and uninterruptedly cyclically administering to said woman a non-aromatizing androgenic compound.
A method of treating hormonal deficiencies in a woman undergoing estrogen replacement therapy comprising continuously and uninterruptedly administering daily dosages of a therapeutically effective amount of an estrogenic compound equivalent to estradiol dosages of about 0.1 to 3 mg, and continuously and uninterruptedly cyclically administering to said woman a therapeutically effective amount of a non-aromatizing androgenic compound equivalent to oral dosages of about 0.1 to 10 mg.
A pharmaceutical composition for the treatment of female hormonal deficiencies, said composition comprising:
- a therapeutically effective amount of an estrogenic compound;
- a therapeutically effective amount of a non-aromatizing androgenic compound;
- and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.